Sherry Franklin, MD

Pediatric endocrinologist, Medical Director, United Healthcare, Past President San Diego County Medical Society

Sherry Franklin, MD, currently serves as Medical Director at United Healthcare, Children’s Healthcare Medical Associate as well as Assistant Clinical Professor at UC San Diego. She has been board certified in pediatric endocrinology since 2003. Dr. Franklin received her medical degree in 1995, at Texas A&M University. She began her clinical training in general pediatrics at Greenville Memorial Hospital in South Carolina. Dr. Franklin furthered her training in pediatric endocrinology and diabetes at the UCLA Medical Center, training with world renowned experts in diabetes, obesity and disorders of growth. She was also awarded an appointment as a Clinical Instructor at UCLA. Dr. Franklin has served as the Past President of the San Diego Medical Society and is currently affiliated UCSD Medical Hospital and Rady Children’s Hospital. She has been involved with numerous research projects to date; her clinical trials include the following:

Clinical Trials
A Phase IV, Multicenter, Open-Label Study Of The Immunogenicity of Nutropin AQ Administered Daily To Naïve Growth Hormone-Deficiency Children (iStudy); ML29543. Genetech Inc. 03/15-8/16
Post-Approval Safety Study to Monitor the Long-Term Safety and Efficacy of Omnitrope® in Infants, Children and Adolescents. Sandoz, Inc. 10/12-8/16
TrialNet. Natural History Study of the Development of Type 1 Diabetes. NIH. 04/12-8/16
Dexcom’s Next Generation Product Human Factors-Usability Study in Pediatric Age Participants. DexCom, Inc. 10/12
A Four-Year Open-Label Multi—Center Randomized Two-Arm Study of Genotropin in Idiopathic Short Stature patients: Comparing an Individualized, Target-Driven Treatment Regimen to Standard Dosing of Genotropin. Pfizer Pharmaceuticals, Inc. 10/06-11/12
KIGS Patient Registry for Pfizer International Growth Study. Pfizer Pharmaceuticals, Inc. 9/06-2011
GHMonitorSM Patient Registry for Saizen® and™. Serono Pharmaceuticals, Inc. 3/03-2009
GrowTrakPLUS™ Patient Registry for National Cooperative Growth Study. Genentech Pharmaceuticals, Inc. 3/03-2010
Norditropin National Registry. Novo Nordisk Pharmaceuticals, Inc. 4/04-8/16
External Continuous Subcutaneous Infusion of Insulin Aspart (NovoLog®) Versus Insulin Lispro (Humalog®): An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents with Type 1 Diabetes. Novo Nordisk Pharmaceuticals, Inc. 3/05-3/06
Glimepride versus Metformin as Monotherapy in Pediatric Subjects with Type 2 Diabetes Mellitus: A single Blind Comparison Study. Aventis Pharmaceuticals. 7/02-12/03
A multi-Center, Open-Labeled, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys with Hypogonadism. Unimed Pharmaceuticals, Inc. 7/02-12/03
24-Week, Randomized, Double-Blind, Active-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rosiglitazone in Pediatric Patients with Type 2 Diabetes Mellitus. SmithklineBeecham Pharmaceuticals, Inc. 7/02-12/03
Basal/Bolus Therapy with Insulin Aspart (Novolog®) versus Regular Human insulin (Novolin R®) or Insulin Lispro (Humalog®) in combination with NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents with Type 1 Diabetes. Novo Nordisk Pharmaceuticals, Inc. 7/02-12/03
Clinical Investigation to Discover Effects of Actos, on Glycemic Control, in Type 1 Diabetes Mellitus. 7/99-6/02
Sherry Franklin, MD